Pharmaceutical Executive Digest Europe - February 3, 2009 - (Page 10) Interphex 2009 17–19 March • New York, USA A key event for leading-edge technology, education and sourcing of the products and services that drive scientific innovation for life sciences manufacturing from drug development to market. www.interphex.com DIA EuroMeeting 2009 23–25 March Berlin, Germany The many cultural flavours and facets of Europe provide a contrasting perspective to the global drug market. Often aspects of Europe are not fully understood by colleagues around the world and the EuroMeeting provides a “oncea-year opportunity to explain all.” Phone: +41 61 225 5151 Fax: +41 61 225 5152 www.diahome.org World Health Care Congress Europe 2009 13–14 May Brussels, Belgium The 5th Annual World Health Care Congress Europe presents business cases, best practices and strategies for addressing the pressures and current challenges facing European healthcare efficiency, economic stability, access to care, quality care, patient safety and patient mobility within and across borders. Phone: +1 603 472 7494 www.worldcongress.com/europe ON THE MOVE Belgian company OncoMethylome has appointed Gerard Vaillant to its board of directors. Mr Vaillant replaces Dr Christian Schneider. The company has also hired Gert-Jan Renardel de Lavalette as its chief operating officer. Eden Biodesign (UK), a provider of biopharmaceutical process development and cGMP manufacturing services, has appointed Maria Lusk as director of Client Management at its US subsidiary, Eden Biodesign, Inc. Maria’s appointment marks the formal establishment of the company’s US project management function, and coincides with the expansion of the US office, as Eden Biodesign, Inc. formally moves to North Carolina’s biotech hub, Research Triangle Park, North Carolina. Maria has 17 years’ experience within the biotechnology and pharmaceutical industry. and CEO of OXiGENE, as its new CEO. The US-based, non-profit pharmaceutical company develops drugs for people with neglected infectious diseases in the developing world. Dr Chin has overseen over 40 Investigational New Drug (IND) Applications for new molecular entities and new indications, as well as eight New Drug Applications (NDAs)/Biologic License Applications (BLAs), and has The Institute for OneWorld Health has authored a major textbook on clinical named Dr Richard Chin, former president trial medicine. He succeeds Ahvie Herskowitz, the company’s co-founder and current CEO. DxS Ltd (Manchester, UK), a personalised medicine company and leaders in the provision of companion diagnostics, has today announced the appointment of Jeff Devlin as chief operating officer. Prior to DxS, Mr Devlin held positions as executive VP and executive committee member of Shire Pharmaceuticals, where he played a key role in strategy and integration. 89,760 68,721 92,754 69,451 2 NEWS US and European biopharm salary survey 3 NEWS Boost for Norwegian biotech 4 FROM THE EDITOR Let the mergers begin 5 BRUSSELS REPORT Peter Mandelson steps into the life sciences frame http://www.interphex.com http://www.diahome.org http://www.worldcongress.com/europe
Table of Contents Feed for the Digital Edition of Pharmaceutical Executive Digest Europe - February 3, 2009 Pharmaceutical Executive Digest Europe - February 3, 2009 Contents News From the Editor Brussels Report Comment On the Move Pharmaceutical Executive Digest Europe - February 3, 2009 Pharmaceutical Executive Digest Europe - February 3, 2009 - Contents (Page 1) Pharmaceutical Executive Digest Europe - February 3, 2009 - News (Page 2) Pharmaceutical Executive Digest Europe - February 3, 2009 - News (Page 3) Pharmaceutical Executive Digest Europe - February 3, 2009 - From the Editor (Page 4) Pharmaceutical Executive Digest Europe - February 3, 2009 - Brussels Report (Page 5) Pharmaceutical Executive Digest Europe - February 3, 2009 - Brussels Report (Page 6) Pharmaceutical Executive Digest Europe - February 3, 2009 - Brussels Report (Page 7) Pharmaceutical Executive Digest Europe - February 3, 2009 - Comment (Page 8) Pharmaceutical Executive Digest Europe - February 3, 2009 - Comment (Page 9) Pharmaceutical Executive Digest Europe - February 3, 2009 - On the Move (Page 10)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.